华康生物医学：900万份购股权已获行使

Core Viewpoint - Huakang Biomedical (08622) announced that 9 million stock options granted under the 2020 stock option plan will be exercised on December 9, 2025, in accordance with the rules of the 2020 stock option plan [1] Summary by Category - Stock Options - The company will exercise 9 million stock options as per the 2020 stock option plan [1]